Related Experiment Video
Updated: May 28, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
Coumarin-Amino Acid Hybrids Used as Possible Multifactorial Anti-Inflammatory Agents
Ioannis Fotopoulos1, Dimitra Hadjipavlou-Litina1
1Laboratory of Pharmaceutical Chemistry, School of Pharmacy, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
New coumarin-amino acid hybrids show promising antioxidant and anti-inflammatory effects. Compound 4 demonstrates potential as a lead molecule for developing drugs with multiple therapeutic actions.
Area of Science:
- Medicinal Chemistry
- Pharmacology
Background:
- Coumarin derivatives are known for diverse biological activities.
- Amino acid conjugation can modulate pharmacological properties.
Purpose of the Study:
- To synthesize and evaluate novel coumarin-amino acid hybrids.
- To assess their antioxidant and anti-inflammatory potential in vitro.
- To predict their drug-likeness using in silico methods.
Main Methods:
- Synthesis of coumarin-amino acid hybrids.
- In vitro antioxidant assays (AAPH-induced linoleic acid peroxidation).
- In vitro anti-inflammatory assays (Soybean lipoxygenase, Ovine cyclooxygenase-2 inhibition).
- In silico drug-likeness prediction (Molinspiration, SwissADME, etc.).
Main Results:
- Compounds were synthesized in good yields.
- Compound 15 exhibited potent antioxidant activity (93% inhibition).
- Compound 4 was the most effective LOX inhibitor (IC50 = 58 μM).
- Compounds 4 and 5 showed strong COX-2 inhibition (IC50 = 55 μM).
- Compounds 4, 9, and 15 displayed pleiotropic activities.
- In silico analysis revealed favorable drug-like properties (QED > 0.5).
Conclusions:
- Coumarin-amino acid hybrids possess significant antioxidant and anti-inflammatory properties.
- Compound 4 is a promising lead for developing pleiotropic anti-inflammatory agents.
- In silico predictions support the potential therapeutic applications of these compounds.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Ulcerative Colitis in IBD